The present disclosure relates to endothelial cell-specific molecule 4 genesand encodedpolypeptides and materials and uses thereof in the imaging, diagnosis andtreatment ofconditions involving the vascular endothelium, including cancer, psoriasis,diabetic retinopathy,atherosclerosis or menorrhagia.